Management of Differentiated Thyroid Cancer in the Presence of Resistance to Thyroid Hormone and TSH-Secreting Adenomas: A Report of Four Cases and Review of the Literature

ÜNLÜTÜRK, UĞUR; Sriphrapradang, Chutintorn; ERDOĞAN, MURAT; EMRAL, RIFAT; GÜLDİKEN, SİBEL; Refetoff, Samuel; GÜLLÜ, SEVİM

doi:10.1210/jc.2012-4142

Management of Differentiated Thyroid Cancer in the Presence of Resistance to Thyroid Hormone and TSH-Secreting Adenomas: A Report of Four Cases and Review of the Literature

ÜNLÜTÜRK U., Sriphrapradang C., ERDOĞAN M. F., EMRAL R., GÜLDİKEN S., Refetoff S., ...Daha Fazla

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.98, sa.6, ss.2210-2217, 2013 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Derleme
Cilt numarası: 98 Sayı: 6
Basım Tarihi: 2013
Doi Numarası: 10.1210/jc.2012-4142
Dergi Adı: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.2210-2217
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Ankara Üniversitesi Adresli: Evet

Özet

Background: An increased or normal serum TSH concentration, despite elevated thyroid hormone levels, is observed in resistance to thyroid hormone (RTH) and TSH-secreting adenomas (TSHomas). When coexistent with a differentiated thyroid cancer (DTC), maintenance of a suppression of TSH is challenging.